We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.3B
AUM Growth
+$229M
Cap. Flow
-$342M
Cap. Flow %
-2.78%
Top 10 Hldgs %
11.52%
Holding
627
New
166
Increased
116
Reduced
155
Closed
161

Top Buys

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$167M
2
C icon
Citigroup
C
+$137M
3
A icon
Agilent Technologies
A
+$120M
4
RHT
Red Hat Inc
RHT
+$106M
5
AYI icon
Acuity Brands
AYI
+$103M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$141M
2
SYK icon
Stryker
SYK
+$134M
3
FANG icon
Diamondback Energy
FANG
+$107M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$100M
5
BCR
CR Bard Inc.
BCR
+$87.3M

Sector Composition

Rank Sector Weight
1 Technology 14.15%
2 Healthcare 12.62%
3 Financials 12.54%
4 Industrials 12.05%
5 Consumer Discretionary 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MULE
401
DELISTED
MuleSoft, Inc.
MULE
$1.82M 0.01%
+75,000
New +$1.76M
SYRS
402
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.81M 0.01%
11,383
+29
+0.3% +$3.54K
IPGP icon
403
IPG Photonics
IPGP
$3.82B
$1.8M 0.01%
+14,884
New +$1.68M
FSTX
404
CALL
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$1.78M 0.01%
50,000
– –
XENE icon
405
Xenon Pharmaceuticals
XENE
$6.13B
$1.76M 0.01%
+439,894
New +$3.46M
DAN icon
406
Dana Inc
DAN
$3.06B
$1.75M 0.01%
+90,477
New +$1.75M
REVG
407
DELISTED
REV Group
REVG
$1.72M 0.01%
+62,500
New +$1.69M
BOLD
408
DELISTED
Audentes Therapeutics, Inc
BOLD
$1.71M 0.01%
100,138
+243
+0.2% +$3.93K
VIVE
409
DELISTED
VIVEVE MED INC
VIVE
$1.58M 0.01%
+250
New +$1.22M
WYNN icon
410
Wynn Resorts
WYNN
$10.6B
$1.58M 0.01%
+13,781
New +$1.37M
INSM icon
411
Insmed
INSM
$28.6B
$1.57M 0.01%
89,786
-102,234
-53% -$1.58M
PSV
412
DELISTED
Hermitage Offshore Services Ltd.
PSV
$1.51M 0.01%
+136,912
New +$2.74M
CTXS
413
DELISTED
Citrix Systems Inc
CTXS
$1.49M 0.01%
+17,806
New +$1.39M
KLXI
414
DELISTED
KLX Inc.
KLXI
$1.46M 0.01%
+38,856
New +$1.57M
ANAB icon
415
AnaptysBio
ANAB
$1.67B
$1.45M 0.01%
+52,250
New +$1.22M
ALXN
416
DELISTED
Alexion Pharmaceuticals
ALXN
$1.45M 0.01%
11,924
-775,569
-98% -$100M
NBIX icon
417
Neurocrine Biosciences
NBIX
$16.6B
$1.42M 0.01%
32,892
-612,644
-95% -$26.2M
VTVT icon
418
vTv Therapeutics
VTVT
$139M
$1.38M 0.01%
5,268
-62
-1% -$14.1K
GNCA
419
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.36M 0.01%
27,868
-328
-1% -$12.8K
FSTX
420
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$1.36M 0.01%
38,090
-11,910
-24% -$408K
FENX
421
DELISTED
Fenix Parts, Inc.
FENX
$1.34M 0.01%
866,241
+9,710
+1% +$21.4K
RIGL icon
422
Rigel Pharmaceuticals
RIGL
$753M
$1.32M 0.01%
+40,028
New +$1.02M
FANG icon
423
Diamondback Energy
FANG
$52.6B
$1.31M 0.01%
12,659
-1,040,627
-99% -$107M
FCE.A
424
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$1.31M 0.01%
+60,237
New +$1.33M
MRTX
425
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.31M 0.01%
+251,988
New +$1.38M
15 16
17
18 19

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q1 2017 Portfolio in Review

As of Q1 2017, Alyeska Investment Group held 627 positions worth $12.3B, up 1.9% from $12.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group's Q1 2017 filing shows 166 new, 116 increased, 155 reduced and 161 closed positions. Its largest new stake was Agilent Technologies: 2,378,330 shares worth $126M. The largest sale was Cisco, an estimated $141M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Alyeska Investment Group's largest Q1 2017 buy was Agilent Technologies: 2,378,330 shares worth $126M.
  • Alyeska Investment Group added most to Palo Alto Networks in Q1 2017, an estimated $167M increase.
  • Alyeska Investment Group's biggest Q1 2017 reduction was Cisco, cutting an estimated $141M.
  • Alyeska Investment Group fully exited Stryker in Q1 2017, selling an estimated $134M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $12.3B portfolio in Q1 2017.
  • Alyeska Investment Group opened 166 new positions and closed 161 in Q1 2017.
  • Alyeska Investment Group's portfolio value rose 1.9% quarter-over-quarter to $12.3B.

Based on Alyeska Investment Group's 13F filing for Q1 2017, filed 15 May 2017.